Biotech - Press Releases

Date	Title	Company
14-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
14-Dec-2020	Freeline Reports Updated Data from Phase 1/2 B-AMAZE Trial in Hemophilia B	Freeline
14-Dec-2020	Pepscope Secures Investment to Radically Improve Development and Application of Kinase Inhibitor Therapies	Pepscope
14-Dec-2020	Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science	Calibre Scientific
14-Dec-2020	The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials	Russian Direct Investment Fund
14-Dec-2020	Regent Pacific Completes Acquisition of Deep Longevity, Inc	Regent Pacific Group Limited
14-Dec-2020	Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases	Locanabio, Inc.
14-Dec-2020	Robocath bolsters Strategic Committee with appointment of Chantal Le Chat as independent member	Andrew Lloyd Associates
14-Dec-2020	Sai Life Sciences releases its first Sustainability Report	Sai Life Sciences
14-Dec-2020	Accelerating Innovation, Deepening Integration \| Viva Biotech Online Investor Day Review	Viva Biotech
13-Dec-2020	Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021	Seegene Inc.
13-Dec-2020	Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021	Seegene Inc.
12-Dec-2020	FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine	U.S. Food and Drug Administration
11-Dec-2020	Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares	Sutro Biopharma
11-Dec-2020	Pharming Reports on Extraordinary General Meeting of Shareholders	Pharming Group N.V.
11-Dec-2020	Notice of extraordinary general meeting of Medivir AB (publ)	Medivir
11-Dec-2020	Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock	Protagonist Therapeutics, Inc.
10-Dec-2020	Alpha Solway honours top doctor with new ‘People’s Choice’ award	Alpha Solway
10-Dec-2020	European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs	Aquavit Pharmaceuticals, Inc.
10-Dec-2020	Molecular Assemblies Appoints Phil Paik, Ph.D., Vice President, Platform Development	Molecular Assemblies, Inc.